D.L. Carlson Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.58M Buy
4,983
+2,333
+88% +$2.37M 0.79% 35
2025
Q4
$2.85M Sell
2,650
-18
-0.7% -$17.2K 0.48% 60
2025
Q3
$2.04M Buy
2,668
+182
+7% +$135K 0.34% 74
2025
Q2
$1.94M Sell
2,486
-392
-14% -$305K 0.35% 73
2025
Q1
$2.38M Sell
2,878
-262
-8% -$218K 0.46% 65
2024
Q4
$2.42M Sell
3,140
-35
-1% -$29K 0.43% 64
2024
Q3
$2.81M Sell
3,175
-3,240
-51% -$2.91M 0.51% 59
2024
Q2
$5.81M Sell
6,415
-45
-0.7% -$36K 1.12% 17
2024
Q1
$5.03M Sell
6,460
-160
-2% -$114K 0.98% 28
2023
Q4
$5.02M Buy
6,620
+6,128
+1,246% +$3.58M 1.02% 25
2023
Q3
$264K Buy
+492
New +$254K 0.05% 117

Other funds holding LLY

D.L. Carlson Investment Group's LLY Position: Q1 2026 in Review

D.L. Carlson Investment Group increased its Eli Lilly (LLY) stake by 88% in Q1 2026, buying an estimated $2.37M and bringing the position to 4,983 shares worth $4.58M. The position accounts for 0.79% of the portfolio, ranked #35.

D.L. Carlson Investment Group first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $5.81M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • D.L. Carlson Investment Group held 4,983 shares of Eli Lilly worth $4.58M as of Q1 2026.
  • D.L. Carlson Investment Group bought 2,333 Eli Lilly shares in Q1 2026, an estimated $2.37M.
  • Eli Lilly made up 0.79% of D.L. Carlson Investment Group's portfolio in Q1 2026, its #35 holding.
  • D.L. Carlson Investment Group first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • D.L. Carlson Investment Group's Eli Lilly position peaked at $5.81M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on D.L. Carlson Investment Group's 13F filing for Q1 2026, filed 13 May 2026.